Using advanced technologies to analyze and improve treatment for rare and pediatric cancers
Official title: Integrative Multiomics and Clinical Laboratory Translation for Advanced, Rare, and Pediatric Cancers
Funded at University of Michigan at Ann Arbor · NIH-10977429 · Data updated 2026-11-12
This study is exploring new ways to understand and treat rare and advanced cancers in kids by using the latest technology to look closely at their genes, helping doctors make better decisions for their care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | September 3, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $159,803 |
| NIH project number | 1R50CA293826-01 |
| Project ID | NIH-10977429 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals diagnosed with advanced, rare, or pediatric cancers who may benefit from advanced genomic testing.
✕Less likely to help
Patients with common cancers that are well understood and have established treatment protocols may not receive significant benefits from this research.
What this research studies
This research focuses on utilizing cutting-edge technologies in genomics, transcriptomics, epigenomics, and proteomics to analyze advanced, rare, and pediatric cancers. By developing reportable test results in a clinical lab, the project aims to translate complex genetic information into actionable insights for patient care. The Mi-OncoSeq lab will employ innovative sequencing methods and bioinformatics to enhance the understanding of cancer mechanisms and improve diagnostic and therapeutic decision-making for affected patients.
Why it matters
Potential benefit: If successful, this research could lead to more precise and effective treatment options for patients with advanced, rare, and pediatric cancers.
How similar studies have gone: Previous research has shown promise in using multiomics approaches for cancer analysis, indicating potential for success in this innovative project.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Robinson, Dan Russel — University of Michigan at Ann Arbor
- Study coordinator: Robinson, Dan Russel
Related research
Other NIH-funded projects on the same topics.
-
Expanding genetic testing for cancer risk in patients and families
This study is working to make it easier for cancer patients in Michigan to get genetic testing for cancer risk by improving how doctors gather family history and assess genetic risks, so that more people can receive the important evaluations they need.
-
HEARTS hypertension and diabetes care in Guatemala
This grant tests how well the HEARTS primary care model works in Guatemala to improve blood pressure and blood sugar control for patients.
-
Why the retina can sometimes heal itself and how we might help it heal
This NIH grant explores how inflammation and neural cells interact in the zebrafish retina to understand retinal neuron death and regeneration, with potential implications for human vision.
-
Integrated Heart Health: A HEARTS-based approach to hypertension and diabetes in Guatemala
A study tests a team-based, stepwise care model to improve blood pressure and blood sugar control for people with both hypertension and diabetes in Guatemala.
-
Understanding how work exposures and genes influence ALS risk
A study is building a long-term group of people at higher risk for ALS to see how their jobs, exposures at work, and genes together affect if and when the disease might develop.
-
An integrated mobile health program to reduce SAVA and mental health problems among female sex workers in Kenya
A new mobile health program aims to help female sex workers in Kenya avoid substance abuse, violence, HIV, and depression by delivering group therapy, online resources, and a peer discussion space.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.